Joseph P. Neglia
University of Minnesota
284 Papers
1.7K Citations
Joseph P. Neglia is an academic researcher from University of Minnesota. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 72, co-authored 241 publications. Previous affiliations of Joseph P. Neglia include Children's Oncology Group & Fred Hutchinson Cancer Research Center.
Chat about Author
Papers
Health and risk behaviors in survivors of childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Kris Ann P. Schultz,Lu Chen,Lu Chen,Zhengjia Chen,Lonnie K. Zeltzer,H. Stacy Nicholson,Joseph P. Neglia +6 more
TL;DR: Survivors of childhood acute myeloid leukemia (AML) face increased risks of chronic disease and secondary malignancies and substance exposure may compound these risks.
38
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma
Clarke P. Anderson,Katherine K. Matthay,John P. Perentesis,Joseph P. Neglia,Howard H. Bailey,Judith G. Villablanca,Susan Groshen,Beth Hasenauer,John M. Maris,Robert C. Seeger,C. Patrick Reynolds +10 more
TL;DR: To evaluate BSO‐mediated glutathione (GSH) depletion in combination with L‐PAM for children with recurrent or refractory high‐risk neuroblastoma (NB) as a means to enhance alkylator sensitivity.
36
Pediatric cancer in the United States. A preliminary report of a collaborative study of the childrens cancer group and the pediatric oncology group
Julie A. Ross,Richard K. Severson,Leslie L. Robison,Brad H. Pollock,Joseph P. Neglia,William G. Woods,G. Denman Hammond +6 more
TL;DR: The exact proportion of pediatric patients with cancer who receive care at centers that use up‐to‐date therapeutic protocols (such as those affiliated with the Childrens Cancer Group (CCG) or the Pediatric Oncology Group (POG) is unknown).
35
A randomized controlled pilot trial of a Web-based resource to improve cancer knowledge in adolescent and young adult survivors of childhood cancer
TL;DR: This study examined cancer knowledge in adolescent and young adult (AYA) survivors and pilot tested a Web‐based resource to provide individually tailored information regarding cancer treatment history, late effects risk, and resources.
35
Everyday executive function in standard-risk acute lymphoblastic leukemia survivors
Karin S. Walsh,Iris Paltin,Gerard A. Gioia,Peter K. Isquith,Nina S. Kadan-Lottick,Joseph P. Neglia,Pim Brouwers +6 more
TL;DR: Sparing of extensive and severe EF deficits in SR-ALL survivors overall is suggested, however, a subset of survivors displays clinically significant executive dysfunction, suggesting a heightened susceptibility to disrupted metacognitive functions as survivors age.
34